Pre-Market Most Active Stocks: BZAI, LCID, SRPT, TSLL, BBAI, QS, ETHA, SQQQ, JOBY, ACHR, BABA, NIO

RBC Capital analyst Deane Dray maintains a Buy rating on Xylem with a $155.00 price target. The analyst consensus suggests a Moderate Buy rating with an average price target of $141.56. Xylem has a market cap of $31.56B and a P/E ratio of 34.88.

Xylem Inc. (XYL), a leading provider of water technology solutions, has received a mixed bag of analyst ratings in the past three months, with a consensus leaning towards a Moderate Buy. The market cap of XYL stands at $31.56 billion, and its P/E ratio is 34.88 [1].

Analyst Ratings and Price Targets

RBC Capital analyst Deane Dray maintains a Buy rating on XYL with a price target of $155.00 [1]. The analyst consensus suggests a Moderate Buy rating with an average price target of $141.56, according to TipRanks [1]. The highest price target is $152.00, while the lowest is $125.00 [1].

Recent Analyst Moves

- RBC Capital reiterated a Buy rating on XYL with a price target of $155.00 [1].
- Citi raised its price target to $152.00 from $137.00, reiterating a Buy rating [1].
- TD Cowen stuck to its Hold rating with a price target of $125.00 [1].
- J.P. Morgan initiated a Buy rating with a price target of $148.00 [1].
- Mizuho Securities raised its price target to $125.00 from $114.00, reiterating a Hold rating [1].
- Argus Research reiterated a Buy rating with a price target of $145.00 [1].
- Stifel Nicolaus raised its price target to $141.00 from $140.00, reiterating a Buy rating [1].
- Robert W. Baird lowered its price target to $146.00 from $149.00, reiterating a Buy rating [1].
- Oppenheimer lowered its price target to $145.00 from $150.00, reiterating an Outperform rating [1].
- UBS lowered its price target to $164.00 from $165.00, reiterating a Buy rating [1].
- Deutsche Bank lowered its price target to $145.00 from $155.00, reiterating a Buy rating [1].
- Wolfe Research downgraded XYL to Peer Perform from Outperform [1].
- Seaport Global reiterated a Hold rating [1].
- Goldman Sachs reiterated a Buy rating [1].

Earnings and Sales Forecasts

Next quarter's earnings estimate for XYL is $1.15, with a range of $1.11 to $1.18. The previous quarter's EPS was $1.03. XYL has beaten its EPS estimate 100.00% of the time in the past 12 months [1]. The next quarter's sales forecast for XYL is $2.21 billion, with a range of $2.19 billion to $2.24 billion. The previous quarter's sales results were $2.07 billion. XYL has beaten its sales estimates 75.00% of the time in the past 12 months [1].

Conclusion

Analysts have a mixed view on XYL, with a Moderate Buy consensus and a wide range of price targets. The company's strong earnings and sales performance, coupled with a solid analyst track record, suggest potential upside in the stock. Investors should closely monitor the company's earnings and sales reports for further insights.

References

[1] https://www.tipranks.com/stocks/xyl/forecast